XML 37 R10.htm IDEA: XBRL DOCUMENT
v3.25.0.1

MARKETABLE SECURITIES AND NON-CURRENT INVESTMENTS | 12 Months Ended
--- | ---
Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract] |
MARKETABLE SECURITIES AND NON-CURRENT INVESTMENTS | NOTE 3. MARKETABLE SECURITIES AND NON-CURRENT INVESTMENTS The following is a summary of marketable securities classified as trading and available-for-sale as of December 31, 2024 and 2023 (in millions):
| Cost |  | Unrealized Gains |  | Unrealized Losses |  | Estimated Fair Value
2024 |  |  |  |  |  |  |
Current trading marketable securities: |  |  |  |  |  |  |
Equity securities | $ | 3 |  |  | $ | — |  |  | $ | — |  |  | $ | 3 |
Total trading marketable securities | 3 |  |  | — |  |  | — |  |  | 3 |
Current available-for-sale marketable securities: |  |  |  |  |  |  |
U.S. government and agency debt securities | 165 |  |  | — |  |  | (1) |  |  | 164 |
Mortgage and asset-backed debt securities | — |  |  | — |  |  | — |  |  | — |
Corporate debt securities | 39 |  |  | — |  |  | — |  |  | 39 |
Non-U.S. government debt securities | — |  |  | — |  |  | — |  |  | — |
Total available-for-sale marketable securities | 204 |  |  | — |  |  | (1) |  |  | 203 |
Total current marketable securities | $ | 207 |  |  | $ | — |  |  | $ | (1) |  |  | $ | 206 |
| Cost |  | Unrealized Gains |  | Unrealized Losses |  | Estimated Fair Value
2023 |  |  |  |  |  |  |
Current trading marketable securities: |  |  |  |  |  |  |
Equity securities | $ | 4 |  |  | $ | — |  |  | $ | — |  |  | $ | 4 |
Total trading marketable securities | 4 |  |  | — |  |  | — |  |  | 4 |
Current available-for-sale marketable securities: |  |  |  |  |  |  |
U.S. government and agency debt securities | 963 |  |  | 2 |  |  | (4) |  |  | 961 |
Mortgage and asset-backed debt securities | 3 |  |  | — |  |  | — |  |  | 3 |
Corporate debt securities | 1,891 |  |  | 4 |  |  | (4) |  |  | 1,891 |
Non-U.S. government debt securities | 7 |  |  | — |  |  | — |  |  | 7 |
Total available-for-sale marketable securities | 2,864 |  |  | 6 |  |  | (8) |  |  | 2,862 |
Total current marketable securities | $ | 2,868 |  |  | $ | 6 |  |  | $ | (8) |  |  | $ | 2,866 |
Total current marketable securities that were pledged as collateral for our self-insurance requirements had estimated fair values of $177 and $343 million as of December 31, 2024 and 2023, respectively. The gross realized gains on sales of available-for-sale marketable securities totaled $5, $1 and $0 million in 2024, 2023 and 2022, respectively. The gross realized losses on sales of available-for-sale marketable securities totaled $5, $4 and $3 million in 2024, 2023 and 2022, respectively. There were no material impairment losses recognized on marketable securities during 2024, 2023 or 2022. Unrealized Losses The following table presents the age of gross unrealized losses and fair value by investment category for all securities in a loss position as of December 31, 2024 (in millions):
| Less Than 12 Months |  | 12 Months or More |  | Total
| Fair Value |  | Unrealized Losses |  | Fair Value |  | Unrealized Losses |  | Fair Value |  | Unrealized Losses
U.S. government and agency debt securities | $ | — |  |  | $ | — |  |  | $ | 162 |  |  | $ | (1) |  |  | $ | 162 |  |  | $ | (1) |
Total marketable securities | $ | — |  |  | $ | — |  |  | $ | 162 |  |  | $ | (1) |  |  | $ | 162 |  |  | $ | (1) |
Maturity Information The amortized cost and estimated fair value of marketable securities as of December 31, 2024 by contractual maturity are shown below (in millions). Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations with or without prepayment penalties.
| Cost |  | Estimated Fair Value
Due in one year or less | $ | 161 |  |  | $ | 161 |
Due after one year through three years | 43 |  |  | 42 |
Due after three years through five years | — |  |  | — |
Due after five years | — |  |  | — |
| 204 |  |  | 203 |
Equity securities | 3 |  |  | 3 |
| $ | 207 |  |  | $ | 206 |
Non-Current Investments We hold non-current investments that are reported within Other Non-Current Assets in our consolidated balance sheets. Cash paid for these investments, excluding investments obtained through business acquisitions, is included in Other investing activities in our statements of consolidated cash flows. •Equity method investments: As of December 31, 2024 and 2023, equity securities accounted for under the equity method had carrying values of $304 and $295 million, respectively. In 2023, we obtained an equity method investment as part of our acquisition of MNX Global Logistics. See note 8 for a further discussion of business acquisitions. Cash paid for this investment is included in Acquisitions, net of cash acquired in our statement of consolidated cash flows. •Other equity securities: Certain equity securities that do not have readily determinable fair values are reported in accordance with the measurement alternative in Accounting Standards Codification Topic 321 Investments – Equity Securities. As of December 31, 2024 and 2023, we had equity securities of $42 and $47 million, respectively, accounted for under this measurement alternative. •Other investments: We hold an investment in a variable life insurance policy to fund benefits for the UPS Excess Coordinating Benefit Plan. The investment had a fair market value of $19 million as of December 31, 2024 and 2023, respectively. Fair Value Measurements Marketable securities valued utilizing Level 1 inputs include active exchange-traded equity securities and equity index funds, certificates of deposits, and most U.S. government debt securities, as these securities all have quoted prices in active markets. Marketable securities valued utilizing Level 2 inputs include asset-backed securities, most corporate bonds and municipal bonds. These securities are valued using market corroborated pricing, matrix pricing or other models that utilize observable inputs such as yield curves. The following table presents information about our investments measured at fair value on a recurring basis as of December 31, 2024 and 2023, and indicates the fair value hierarchy of the valuation techniques utilized to determine such fair value (in millions):
| Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Total
2024 |  |  |  |  |  |  |
Marketable Securities: |  |  |  |  |  |  |
U.S. government and agency debt securities | $ | 164 |  |  | $ | — |  |  | $ | — |  |  | $ | 164 |
Mortgage and asset-backed debt securities | — |  |  | — |  |  | — |  |  | — |
Corporate debt securities | 25 |  |  | 14 |  |  | — |  |  | 39 |
U.S. state and local municipal debt securities | — |  |  | — |  |  | — |  |  | — |
Equity securities | — |  |  | 3 |  |  | — |  |  | 3 |
Non-U.S. government debt securities | — |  |  | — |  |  | — |  |  | — |
Total marketable securities | 189 |  |  | 17 |  |  | — |  |  | 206 |
Other non-current investments(1) | — |  |  | 19 |  |  | — |  |  | 19 |
Total | $ | 189 |  |  | $ | 36 |  |  | $ | — |  |  | $ | 225 |
(1)Represents a variable life insurance policy funding benefits for the UPS Excess Coordinating Benefit Plan.
| Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Total
2023 |  |  |  |  |  |  |
Marketable Securities: |  |  |  |  |  |  |
U.S. government and agency debt securities | $ | 961 |  |  | $ | — |  |  | $ | — |  |  | $ | 961 |
Mortgage and asset-backed debt securities | — |  |  | 3 |  |  | — |  |  | 3 |
Corporate debt securities | — |  |  | 1,891 |  |  | — |  |  | 1,891 |
U.S. state and local municipal debt securities | — |  |  | — |  |  | — |  |  | — |
Equity securities | — |  |  | 4 |  |  | — |  |  | 4 |
Non-U.S. government debt securities | — |  |  | 7 |  |  | — |  |  | 7 |
Total marketable securities | 961 |  |  | 1,905 |  |  | — |  |  | 2,866 |
Other non-current investments(1) | — |  |  | 19 |  |  | — |  |  | 19 |
Total | $ | 961 |  |  | $ | 1,924 |  |  | $ | — |  |  | $ | 2,885 |
(1)Represents a variable life insurance policy funding benefits for the UPS Excess Coordinating Benefit Plan.
There were no transfers of investments into or out of Level 3 during 2024 or 2023.

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration